Skip to main content
Clinical Trials/ACTRN12611000147987
ACTRN12611000147987
Completed
N/A

In patients with osteoarthritis of the knee, are patient specific cutting guides used for total knee joint replacement as good as computer-assisted surgery for patient outcomes?

Stryker Australia0 sites100 target enrollmentFebruary 8, 2011

Overview

Phase
N/A
Intervention
Not specified
Conditions
Osteoarthritis of the knee
Sponsor
Stryker Australia
Enrollment
100
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 8, 2011
End Date
April 9, 2018
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Stryker Australia

Eligibility Criteria

Inclusion Criteria

  • The patient is a male or non\-pregnant female between the ages of 50\-80\.
  • \-The patient requires a primary total knee replacement and is indicated for computer\-assisted surgery.
  • \-The patient has a primary diagnosis of osteoarthritis (OA).
  • \-The patient has intact collateral ligaments.
  • \-The patient is able to undergo MRI scanning of the affected limb.
  • \-The patient has signed the study specific, HREC\-approved, Informed Consent document.
  • \-The patient is willing and able to comply with the specified pre\-operative and post\-operative clinical and radiographic evaluations.

Exclusion Criteria

  • \-The patient has a history of total, unicompartmental reconstruction or fusion of the affected joint.
  • \-Patient has had a high tibial osteotomy or femoral osteotomy.
  • \-The patient is morbidly obese (BMI is greater than or equal to 40\).
  • \-The patient has a deformity which will require the use of stems, wedges or augments in conjunction with the Triathlon Total Knee System.
  • \-The patient has varus or valgus malalignment greater than or equal to 15 degrees (relative to mechanical axis).
  • \-The patient has a fixed flexion deformity greater than or equal to 15 degrees.
  • \-The patient has a neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.
  • \-The patient has a systemic or metabolic disorder leading to progressive bone deterioration.
  • \-The patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements.
  • \-Patient has a cognitive impairment, an intellectual disability or a mental illness.

Outcomes

Primary Outcomes

Not specified

Similar Trials